Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag for Chemotherapy-Induced Thrombocytopenia
NCT03471078Phase 3Completed
- Sponsor
- Sobi
- Start
- Oct 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of avatrombopag in chemotherapy-induced thrombocytopenia (CIT), sponsored by Sobi. Started Oct 2018; status: completed.
02
Drugs
avatrombopag
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on NCT03471078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03471078.